Simpson, MeganNarwal, AnujWest, EricMartin, JillBagot, Catherine NPage, Andrew RWatson, Henry GWhyte, Claire SMutch, Nicola J2023-12-062023-12-062023-12Simpson, M, Narwal, A, West, E, Martin, J, Bagot, C N, Page, A R, Watson, H G, Whyte, C S & Mutch, N J 2023, 'Fibrinogenolysis and fibrinolysis in Vaccine-induced Immune Thrombocytopenia and Thrombosis (VITT)', Journal of Thrombosis and Haemostasis, vol. 21, no. 12, pp. 3589-3596. https://doi.org/10.1016/j.jtha.2023.09.0071538-7933ORCID: /0000-0002-3824-8808/work/143412750ORCID: /0000-0001-8127-6102/work/143414335ORCID: /0000-0002-7452-0813/work/169538880https://hdl.handle.net/2164/22349Acknowledgements The authors would like to thank all the patients whose samples were used as part of this study, and all the NHS Scotland staff who collected patient samples and looked after these patients. We thank Aberdeen Royal Infirmary Haematology laboratory for conducting the anti-platelet factor 4 antibody testing and Dr Sue Pavord, Consultant Haematologist at Oxford Teaching Hospitals for help in gathering clinical data on the patients. Funding This research was supported by The University of Aberdeen Development Trust (RG16009). CSW and NJM are supported by the British Heart Foundation (PG/15/82/31721; PG/20/17/35050).81412911engSubstantive connection via an eligible employment contractSDG 3 - Good Health and Well-beingFibrinolysisplasminthrombosisvaccineR MedicineBritish Heart FoundationPG/20/17/35050PG/15/82/31721OtherRG16009RJournal article10.1016/j.jtha.2023.09.0072112